Dr Jordan B Peterson and Dr. Del Paulhus delve deep into the Dark Tetrad: Machiavellianism, Narcissism, Psychopathy, and the newly added Sadism. From these four traits, researchers can quantify much of the darkness of humanity, and begin to study it in a way that yields numerical results, and the potential to make substantial predictions.
Dr. Delroy Paulhus is a personality researcher whose work in dark personality traits, via a variety of psychometric methods, has yielded measures of the Dark Tetrad. His work has also validated measures of socially desirable responding, perceived control, free will and determinism, and over-claiming. His work has been published in over 150 articles and books, and his current citation count exceeds 43,000.
One of the most concerning outcomes following surgery and anesthesia among older adults is a condition known as postoperative cognitive dysfunction (POCD). Often, patients and their family members report feeling very fearful that the patient will suffer permanent cognitive deficits after anesthesia. Unfortunately, this pre-emptive fear may contribute to the complex array of symptoms associated with POCD and further complicate the ability to fully understand the subjective experience of this postoperative complication.
About the study
The current study published in the British Journal of Anesthesia involved the collection of data from the comments section of the published article titled ‘The hidden long-term risks of surgery.’ The comments were given an alphanumeric code to maintain chronological order and structure, while the username, submission date, and time were kept anonymous.
To ensure your survival, your brain evolved to avoid one thing: uncertainty. As neuroscientist Beau Lotto points out, if your ancestors wondered for too long whether that noise was a predator or not, you wouldn’t be here right now. Our brains are geared to make fast assumptions, and questioning them in many cases quite literally equates to death. No wonder we’re so hardwired for confirmation bias. No wonder we’d rather stick to the status quo than risk the uncertainty of a better political model, a fairer financial system, or a healthier relationship pattern. But here’s the catch: as our brains evolved toward certainty, we simultaneously evolved away from creativity—that’s no coincidence; creativity starts with a question, with uncertainty, not with a cut and dried answer. To be creative, we have to unlearn millions of years of evolution. Creativity asks us to do that which is hardest: to question our assumptions, to doubt what we believe to be true. That is the only way to see differently. And if you think creativity is a chaotic and wild force, think again, says Beau Lotto. It just looks that way from the outside. The brain cannot make great leaps, it can only move linearly through mental possibilities. When a creative person forges a connection between two things that are, to your mind, so far apart, that’s a case of high-level logic. They have moved through steps that are invisible to you, perhaps because they are more open-minded and well-practiced in questioning their assumptions. Creativity, it seems, is another (highly sophisticated) form of logic. Beau Lotto is the author of Deviate: The Science of Seeing Differently.
Why do some people love Impressionist paintings like Claude Monet’s “Water Lilies” (1906) while others can’t understand the hype? The question of aesthetic taste has stumped scholars for centuries. Now, neuroscientists at the California Institute of Technology (CalTech) say they have come closer to decoding how the brain decides which artworks it deems good or attractive.
In a study published in the scientific journal Nature Communications, CalTech Professor John O’Doherty and other researchers propose that the mind creates an opinion of an artwork after dissecting it into discrete elements. Basic features, such as color and texture, and complex qualities, like style, are ranked and weighed individually to make a judgment.
“People on metformin have 30% lower rates of almost every kind of cancer. It delays cognitive decline. Even people with diabetes who are obese and have more disease to start with but are on metformin have lower mortality rates than people without diabetes who aren’t on the drug.”
What he says is born out in numerous studies. Overall, this safe, super-cheap, decades-old drug not only treats diabetes, but it also seems to delay and compress the years of chronic illness associated with the final stage of life and extend what geroscientists call the “healthspan.”
Metformin is just one of many medications, including other old ones and some brand new inventions, that academic researchers and biotech startups are exploring to slow, stop, or perhaps even reverse aging.
While the mental has often played second fiddle to the physical when it comes to longevity research, this is changing – and not a moment too soon.
The physical and mental aspects of aging are interconnected, and given the strong connection between psychology and the physical pace of aging, poor mental health is starting to be recognised as a major driver of aging.
A raft of developments have demonstrated that physical lifespan and healthspan can be extended and improved, and now it is time for the longevity industry to achieve similar success when it comes to mental health. Sergey Jakimov, the CEO of Swiss investment group LongeVC agrees, and tells us why it’s time for VCs to get excited about backing startups delivering cutting-edge solutions for mental healthcare.
Elon Musk/courtesy of Yichuan Cao/NurPhoto via Getty Images
In 2022, Elon Musk’s Neuralink tried – and failed – to secure permission from the FDA to run a human trial of its implantable brain-computer interface (BCI), according to a Reuters report published Thursday.
Citing seven current and former employees, speaking on the condition of anonymity, Reuters reported that the regulatory agency found “dozens of issues” with Neuralink’s application that the company must resolve before it can begin studying its tech in humans.
Conor russomanno, founder and CEO of openbci eva esteban, embedded software engineer at openbci
Galea is an award-winning platform that merges next-generation biometrics with mixed reality. It is the first device to integrate a wide range of physiological signals, including EEG, EMG, EDA, PPG, and eye-tracking, into a single headset. In this session, Conor and Eva will provide a live demonstration of the device and its capabilities, showcasing its potential for a variety of applications, from gaming to training and rehabilitation. They will give an overview of the different hardware and software components of the system, highlighting how it can be used to analyze user experiences in real time. Attendees will get an opportunity to ask questions at the end.
